Healogics, Inc. Named one of
Healogics, Inc. Ranks on the 2013 Inc. 500|5000
with Three-Year Sales Growth of 260%
America’s Fastest-Growing Private Companies on The Inc.500|5000
JACKSONVILLE, FLA (September 17, 2013) -- Inc.
magazine recently ranked Healogics, Inc. on its seventh annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies. Healogics, Inc. joins LivingSocial, Edible Arrangements, CDW and Lifelock, among other prominent brands featured on this year’s list.
“It is an honor to be named to the Inc.5000 list for 2013. Chronic wounds affect millions of people each year yet only about 1/3 of the hospitals in the U.S. have a physician-led wound care center,” said Jeff Nelson, president and CEO of Healogics, Inc. “Our growth represents improved access for patients to specialized care that could otherwise result in poor outcomes and increased cost to the health care system.” Nelson goes on to say, “Healogics continues to look for innovative ways to reach and treat people with chronic wounds, everywhere we can, through the best means available.”
In a stagnant economic environment, median growth rate of 2013 Inc. 500|5000 companies is an impressive 142 percent. The companies on this year’s list report having created over 520,000 jobs in the past three years, and aggregate revenue among the honorees reached $241 billion. "Not all the companies in the Inc. 500 | 5000 are in glamorous industries, but in their fields they are as famous as household name companies simply by virtue of being great at what they do. They are the hidden champions of job growth and innovation, the real muscle of the American economy,” says Inc
. Editor Eric Schurenberg.
Modern Healthcare names Healogics one of “Healthcare’s Hottest” companies for 2013
JACKSONVILLE, Fla. (September 4, 2013) – Healogics, Inc., the nation’s largest provider of advanced wound care services, has been recognized as one of Modern Healthcare’s list of ‘Healthcare’s Hottest’ companies for 2013.
Modern Healthcare’s ‘Healthcare’s Hottest’ program named the 40 fastest growing companies in various sectors of the healthcare industry. To be eligible, the organization must have generated a minimum of $20 million in annual revenue in the most recent fiscal year.
Healogics and its affiliated companies partner with more than 550 hospitals in the United States to provide advanced wound care services across the care continuum and treat approximately 200,000 patients per year. Healogics has treated more than 2 million wounds and continues to explore opportunities to reach more patients in additional care settings and underserved geographic areas.
“It is a great accomplishment to be named as one of Modern Healthcare’s ‘Healthcare’s Hottest’ companies for 2013. The professionals at Healogics strive to develop new ways to reach patients with chronic, non-healing wounds. The chronic wound epidemic continues to affect millions of people in the U.S. and is growing as the population ages and the incidences of diabetes and obesity increase,” said Healogics president and CEO Jeff Nelson. “As we continue to grow our business, we remain committed to healing patients everywhere we can, by the best means available.”
The ranked order list of Modern Healthcare’s ‘Healthcare’s Hottest’ companies for 2013 will be published in September.
Healogics and The Ohio State University Renew Partnership
JACKSONVILLE, Fla. (September 3, 2013) – Healogics, Inc., the nation’s largest provider of advanced wound care services, has announced an agreement to continue its partnership with The Ohio State University in Columbus, Ohio. Since 2004, Healogics and OSU have been working together through clinical research and education, to directly impact the wound care industry. Healogics brings a myriad of operational and clinical best practices to effectively and efficiently manage The Ohio State University Wexner Medical Center’s Comprehensive Wound Center.
Chronic wounds affect millions of people in the U.S. and the incidence is rising, fueled by an aging population and increasing rates of diseases and conditions such as diabetes, obesity, and the late effects of radiation therapy. Untreated, chronic wounds can lead to diminished quality of life and possibly amputation of the affected limb. Healogics and OSU have made a commitment to raise awareness of the chronic wound epidemic to help more patients get the care they need.
“Effective academic-industry partnership is key to transforming health care. It is an extraordinary opportunity to transform clinical care, education and research nationwide,” said Chandan Sen, PhD, Professor of Surgery and Executive Director, Ohio State’s Comprehensive Wound Center.
“The combination of Healogics’ operational, clinical and financial expertise with OSU’s world-class research is a formula for success. We continue to look to OSU to help us advance the field of regenerative medicine, to translate healing from bench to bedside,” said Healogics president & CEO Jeff Nelson.
In March 2014, Healogics and OSU will host the first annual Science and Industry Summit, an event that will bring together dynamic business leaders and cutting-edge scientists in the field of advanced wound care. The Summit will be held in conjunction with the 7th Annual Translational to Clinical Regenerative Medicine Conference (http://regenerativemedicineconference.osu.edu), a CME event hosted by The Ohio State University Wexner Medical Center.
Healogics Clinical Experts’ Research Study Published Online In Journal of the American Medical Association (JAMA) Dermatology
JACKSONVILLE, Fla. (July 31, 2013) – Healogics, Inc., the nation’s largest provider of advanced wound care services, today announced the recent online publication of research study results authored by a team of clinical experts, James R. Wilcox, RN and D. Scott Covington, MD as well as Marissa J. Carter, PhD, MA in the Journal of the American Medical Association (JAMA) Dermatology. The research study titled “Frequency of Debridements and Time to Heal: A Retrospective Cohort Study of 312,744 Wounds”, examines the importance of frequent debridement as it relates to reducing the potential time to heal complex wounds. Highlights of the study include the following:
More than 312,000 wounds of all types were analyzed in 115,000 patients, making this study the largest, most comprehensive work to date on debridement and healing outcomes.
The study found that more frequent debridement, performed weekly, was associated with faster healing times (P< .001).
“I am very excited and honored to have our results of this study published in JAMA Dermatology,” said James R. Wilcox, RN, Director of Research and Quality of Healogics. “This study adds further depth to our commitment to lead the way in developing and implementing the best possible clinical practice guidelines based on available data and research.”
Scott Covington, MD, Executive Vice President for Medical Affairs of Healogics said, “The results of this study provide clear and compelling evidence of the critical role that the appropriate timing and frequency of debridement plays in the healing of complex wounds.”
Click here to read the full study
Linda Ellis Joins Healogics, Inc. as President of Healogics Specialty Physicians
JACKSONVILLE, Fla. (July 26, 2013) – Healogics, Inc., the nation’s largest provider of advanced wound care services, has added Linda Ellis to their leadership team as President of the Healogics Specialty Physicians business unit.
“I am pleased to announce the addition of another highly respected, experienced leader to our management team,” said Jeffrey W. Nelson, chief executive officer of Healogics. “Linda brings our leadership team a deep well of skills and experiences in working with and leading physicians.” Nelson continued, “As we continue to invest in and expand our Healogics Specialty Physicians business, Linda will provide the leadership to guide our strategy and execution as part of our growth in treating the significant and expanding problem that chronic wounds represent. Our Healogics Specialty Physicians take the evidence-based wound care techniques utilized in Healogics Wound Care Centers throughout the country, and deliver them across the continuum of care. Whether it be in an outpatient Wound Care Center or a skilled nursing facility, they are there to provide excellent patient care. Our continued and growing direct partnership with physicians is a critical element in our growth strategy. Linda will work collaboratively with Chris Morrison, MD, FCCWS, FACHM, executive medical director of Healogics Specialty Physicians in this effort.”
Linda Ellis most recently held the role as Chief Operating Officer for CogentHMG following various senior operational leadership roles at Sterling Healthcare and EMCARE. Linda is a nurse by training, and has also held various hospital leadership roles including Director of Nursing and Vice President of Patient Care.